Notin, Pascal
Rollins, Nathan
Gal, Yarin
Sander, Chris
Marks, Debora http://orcid.org/0000-0001-9388-2281
Article History
Received: 1 July 2023
Accepted: 5 January 2024
First Online: 15 February 2024
Competing interests
: D.M. is an advisor for Dyno Therapeutics, Octant, Jura Bio, Tectonic Therapeutic and Genentech and a cofounder of Seismic. N.R. is employed by Seismic. C.S. is on the scientific advisory board of CytoReason. The other authors declare no competing interests.